Boceprevir Use in Fran A Markov Model of Disease Progression and Cost-Effectiveness for Chronic Hepatitis C (Virus G1)
Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.213
https://www.valueinhealthjournal.com/article/S1098-3015(13)02118-9/fulltext
Section Title :
Disease-Specific Studies
Section Order :
200
First Page :
A359
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02118-9&doi=10.1016/j.jval.2013.08.213